The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.Learn More
Singapore is the world 12th largest pharmaceuticals producer, and over 30 drug producers have a research and development presence in Singapore including Novartis, Eli Lilly, Takeda and GSK. Singapore has a highly developed physical and regulatory infrastructure, skilled manpower and easy access to rapidly expanding Asian markets. Although pharmaceutical companies may be dealing with a sluggish economic growth in Singapore, Euromonitor expects the country to remain a leading mediator between western companies and growing Asian markets.
Watch on YouTube